Related Experiment Video
Updated: Jun 15, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Tyrosinase inactivation in its action on dopa
J L Muñoz-Muñoz1, J R Acosta-Motos, F Garcia-Molina
1GENZ: Grupo de Investigación Enzimología, Departamento de Bioquímica y Biología Molecular-A, Facultad de Biologia, Universidad de Murcia, E-30100, Espinardo, Murcia, Spain.
Biochimica Et Biophysica Acta
|March 11, 2010
Summary
Tyrosinase inactivation by L-dopa occurs under aerobic and anaerobic conditions. Aerobic inactivation is a slower suicide process, while anaerobic inactivation is faster, affecting multiple enzyme forms.
Area of Science:
- Biochemistry
- Enzymology
- Protein chemistry
Background:
- Tyrosinase is a key enzyme in melanin biosynthesis.
- Understanding tyrosinase inactivation is crucial for controlling pigmentation and related disorders.
- The enzyme's stability and reaction mechanisms are subjects of ongoing research.
Purpose of the Study:
- To investigate the mechanisms of tyrosinase irreversible inactivation.
- To compare inactivation processes under aerobic and anaerobic conditions.
- To elucidate the role of different tyrosinase forms in substrate-induced inactivation.
Main Methods:
- Enzyme kinetics studies under varying oxygen conditions.
- Analysis of tyrosinase inactivation kinetics with L-dopa and D-dopa.
- Spectroscopic methods to characterize enzyme intermediates.
Main Results:
- Tyrosinase undergoes irreversible inactivation by L-dopa under both aerobic and anaerobic conditions.
- Aerobic inactivation involves oxy-tyrosinase in a slower suicide mechanism.
- Anaerobic inactivation affects met- and deoxy-tyrosinase forms and proceeds more rapidly.
- Enzyme affinity for D-dopa is lower than for L-dopa, but inactivation velocity remains similar.
Conclusions:
- L-dopa induces distinct irreversible inactivation pathways for tyrosinase depending on oxygen availability.
- The proposed mechanisms highlight the complex regulatory processes governing tyrosinase activity.
- These findings contribute to a deeper understanding of enzyme stability and substrate interactions.
More Related Videos
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...